Murray Mark J.

CIK 00016283831 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001628383

Recent Transactions

15 trades

Award
Arbutus Biopharma Corp$ABUS
Employee Stock Option (Right to Buy)
2019-03-01+357,500→ 357,500 total
Exercise/Conversion
Arbutus Biopharma Corp$ABUS
Employee Stock Option (Right to Buy)
2018-11-28−25,000→ 0 total
Exercise/Conversion
Arbutus Biopharma Corp$ABUS
Common Shares
2018-11-28$1.35/sh+25,000→ 341,396 total
Exercise/Conversion
Arbutus Biopharma Corp$ABUS
Employee Stock Option (Right to Buy)
2018-04-17−27,007→ 0 total
Exercise/Conversion
Arbutus Biopharma Corp$ABUS
Common Shares
2018-04-17$0.35/sh+27,007→ 316,396 total
Award
Arbutus Biopharma Corp$ABUS
Employee Stock Option (Right to Buy)
2018-04-16+418,187→ 418,187 total
Award
Arbutus Biopharma Corp$ABUS
Employee Stock Option (Right to Buy)
2017-03-24+450,000→ 450,000 total
Exercise of In-Money
Arbutus Biopharma Corp$ABUS
Warrants
2016-06-16−5,000→ 0 total
Exercise of In-Money
Arbutus Biopharma Corp$ABUS
Common Shares
2016-06-16$2.57/sh+5,000→ 289,389 total
Award
Arbutus Biopharma Corp$ABUS
Employee Stock Option (Right to Buy)
2016-03-15+450,000→ 450,000 total
Exercise/Conversion
Arbutus Biopharma Corp$ABUS
Common Shares
2015-09-11$0.44/sh+219,428→ 284,389 total
Exercise/Conversion
Arbutus Biopharma Corp$ABUS
Employee Stock Option (right to buy)
2015-09-11−219,428→ 0 total
Award
Arbutus Biopharma Corp$ABUS
Employee Stock Option (right to buy)
2015-07-09+100,000→ 100,000 total
Award
Arbutus Biopharma Corp$ABUS
Employee Stock Option (right to buy)
2015-07-09+100,000→ 100,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (right to buy)
2015-03-30+180,000→ 180,000 total

Companies

Arbutus Biopharma Corp
Director, President & CEO
$ABUS

Recent Filings

Address

C/O TEKMIRA PHARMACEUTICALS CORP. SUITE 100, 8900 GLENLYON PARKWAY

BURNABY, A1, V5J 5J8

View on SEC.gov